|
|
|
|
|
|
|
|
Cheng Li Lab of Computational Cancer Genomics
Research Interests How do genomic changes in the cell promote cancer initiation and progression, and can be used to predict patient response and prognosis? We are developing analysis models and software for high-throughput sequencing and microarray data, and working with biologists and clinicians to study genomics, expression, and network changes in cancer cells towards novel drug targets. We have provided the new analysis methods through user-friendly software such as the widely-used dChip (cited 2100 times) and ComBat (cited 140 times).
Research Support National Institutes of Health, Claudia Adams Barr Program, and Friends of DFCI.
Address Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute Room 11036, Center for
Life Sciences Building, 3
Blackfan Circle, Boston, MA 02115 Email: lch3000@gmail.com Phone: 617-632-3498 Up-to-date webpage: www.ChengLiLab.org (on Google Sites)
|
|
|
|
